{
    "Trade/Device Name(s)": [
        "ONLINE TDM Phenobarbital"
    ],
    "Submitter Information": "Roche Diagnostics Corporation",
    "510(k) Number": "K071644",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951595"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DLZ"
    ],
    "Summary Letter Date": "June 14, 2007",
    "Summary Letter Received Date": "June 15, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3660"
    ],
    "Regulation Name(s)": [
        "Phenobarbital test system"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology",
        "chemistry"
    ],
    "Analyte(s)": [
        "Phenobarbital"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche Hitachi 912",
        "Roche Hitachi 917",
        "Roche Modular P"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ONLINE TDM Phenobarbital enzyme immunoassay for quantitative phenobarbital determination on Roche clinical chemistry analyzers",
    "Indications for Use Summary": "Quantitative determination of phenobarbital in human serum or plasma to aid diagnosis, treatment, and monitoring of phenobarbital use or overdose on Roche automated clinical chemistry analyzers.",
    "fda_folder": "Toxicology"
}